文献速递消化、代谢与肾脏急症儿科与产科急症

两名镰状细胞病患儿接受一氧化二氮后急性阴茎异常勃起缓解

Resolution of Acute Priapism in Two Children With Sickle Cell Disease Who Received Nitrous Oxide.
PubMed 文献 · Acad Emerg Med · 2019-08-01
一句话结论两例Hb-SS青少年阴茎异常勃起在口服治疗失败后,吸入一氧化二氮(最高60%)4–15分钟内完全缓解,作者认为可考虑作为阿片类药物保留的潜在选择。

本文为病例系列,报告两名Hb-SS青少年男孩共3次因急性阴茎异常勃起就诊急诊,均口服伪麻黄碱和阿片类药物失败。一氧化二氮用于辅助静脉置管,每次在吸入一氧化二氮(最高60%)后4–15分钟内阴茎异常勃起完全缓解,每次均从急诊离院,随后一周无复发。作者认为,鉴于当前推荐疗法的风险和效果不一致,一氧化二氮可能代表一种阿片类药物保留的潜在治疗选择,但需进一步研究;尽管为个案经验,在急诊医生选择有限时可考虑吸入一氧化二氮。

要点

  • 两名Hb-SS青少年男孩共3次急性阴茎异常勃起,口服伪麻黄碱和阿片类药物失败后使用一氧化二氮。
  • 每次吸入一氧化二氮(最高60%)后4–15分钟内阴茎异常勃起完全缓解。
  • 每次均从急诊离院,随后一周无复发。
  • 一氧化二氮起效<5分钟、恢复<5分钟,无需静脉通路,无需肝肾代谢,无过敏反应报告。
  • 作者认为一氧化二氮可能代表一种阿片类药物保留的潜在治疗选择,但需进一步研究。

适用人群与场景

  • 两名Hb-SS青少年男孩(患者1在8岁和10岁时各一次,患者2在15岁时一次),共3次因急性阴茎异常勃起就诊于儿科急诊。
  • 每次就诊前口服治疗(伪麻黄碱和阿片类药物)失败。

处置流程与药物剂量

  • 一氧化二氮用于辅助静脉置管,每次给予一氧化二氮(最高60%)。
  • 吸入一氧化二氮后4–15分钟内阴茎异常勃起完全缓解。

研究设计与关键结果

  • 病例系列:两名Hb-SS青少年男孩共3次急性阴茎异常勃起,口服伪麻黄碱和阿片类药物失败后使用一氧化二氮。
  • 每次吸入一氧化二氮(最高60%)后4–15分钟内阴茎异常勃起完全缓解。
  • 每次均从急诊离院,随后一周无复发。

证据类型、等级与局限

  • 证据类型:病例系列(两例患者共3次就诊)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,鉴于当前推荐疗法的风险和效果不一致,一氧化二氮可能代表一种阿片类药物保留的潜在治疗选择,但需进一步研究。
  • 作者认为,尽管为个案经验,在急诊医生选择有限时可考虑吸入一氧化二氮。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Nitrous oxide (N O) is an inhalational medication that has anxiolytic, amnestic, potent venodilatory and mild-to-moderate analgesic properties commonly used in the emergency department (ED) setting. N2 O has a rapid onset of action (<5 minutes) and recovery (<5 minutes) and can be quickly titrated to effect without the need for IV access. It has few side effects, does not require renal or hepatic metabolism for excretion and has no reports of allergic reaction. Priapism is a serious complication of sickle cell disease (SCD) affecting approximately 35% of males, with an adverse impact on quality of life. Treatment options are limited and not evidence based, including hydration, alkalization, analgesia, oxygenation to prevent further sickling, and exchange transfusion. Patients who do not respond within 4 hours often require a painful invasive procedure that includes aspiration of blood from the corpus cavernosum and phenylephrine injections. Case reports have described a therapeutic benefit from oral pseudoephedrine, sildenafil, and intravenous (IV) arginine, however controlled clinical trials are lacking. Although a 50:50 nitrous oxide/oxygen mix is commonly used in France to enhance analgesia in patients with SCD and vasoocclusive pain events (VOE) not sufficiently responding to IV morphine, there are no reports of its use to treat priapism. We describe the effects of N2 O for the treatment of acute priapism associated with SCD in a pediatric ED.

METHODS: This is a case series of two adolescent boys with Hb-SS who on 3 separate occasions presented to the ED with acute priapism that failed oral therapy (pseudoephedrine and opioids). N2 O gas was utilized to help facilitate IV catheter placement.

RESULTS: In each presentation (at ages 8 and 10 years for patient 1; age 15 years for patient 2), the patient experienced complete resolution of the priapism within 4-15 min of receiving N2 O (max 60%). The patients were discharged from the ED following each presentation and had no recurrence during the subsequent week.

CONCLUSIONS: Priapism is a challenging complication of SCD associated with long-term morbidity and a paucity of treatment options. Opioids are commonly used. Given the risks and inconsistent results of current recommended therapy, N2 O may represent a potential opioid-sparing treatment option for priapism presenting to the ED that warrants further investigation. Although anecdotal, N2 O inhalation is an intervention to consider during a time when a treating ED physician may have few alternatives.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Greenwald MH, Gutman CK, Morris CR, et al. Resolution of Acute Priapism in Two Children With Sickle Cell Disease Who Received Nitrous Oxide. Acad Emerg Med. 2019. PMID: 31228879. doi:10.1111/acem.13822

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。